Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel Disease
{{output}}
Background and aims: Timely access to approved medications is a priority in paediatric inflammatory bowel disease [IBD]. To date, the timing of drug studies in paediatric IBD has been suboptimal, with most studies conducted long ... ...
